Inhibrx Biosciences, Inc. Common Stock
Symbol: INBX (NASDAQ)
34.88
▲ (10.66%) 3.360
Company Description:
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
Key Stats
- Today's Open: $34.734
- Today's High: $34.88
- Today's Low: $34.734
- Today's Volume: 112
- Yesterday Close: $31.52
- Yesterday High: $37.6
- Yesterday Low: $30.39
- Yesterday Volume: 370.14K
- Last Min Volume: 10
- Last Min High: $34.88
- Last Min Low: $34.88
- Last Min VWAP: $34.88
Company Profile
- Name: Inhibrx Biosciences, Inc. Common Stock
- Website: https://www.inhibrx.com
- Listed Date: 2024-05-28
- Location: LA JOLLA, CA
- Market Status: Active
- CIK Number: 0002007919
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $543.49M
- Round Lot: 100
- Outstanding Shares: 14.49M
- Asset Type: CS
RECENT FILINGS FOR INBX
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-17 | SCHEDULE 13G/A | View |
| 2025-10-09 | 4 | View |
| 2025-08-13 | 8-K | View |
| 2025-08-13 | 10-Q | View |
| 2025-06-04 | EFFECT | View |
| 2025-06-02 | POS AM | View |
| 2025-05-29 | 4 | View |
| 2025-05-29 | 4 | View |
| 2025-05-29 | 4 | View |
| 2025-05-29 | 4 | View |
| 2025-05-28 | 424B3 | View |
| 2025-05-28 | 8-K | View |
| 2025-05-14 | 424B3 | View |
| 2025-05-14 | 8-K | View |
| 2025-05-14 | 10-Q | View |
| 2025-04-18 | EFFECT | View |
| 2025-04-17 | POS AM | View |
| 2025-04-17 | ARS | View |
| 2025-04-16 | DEFA14A | View |
| 2025-04-16 | DEF 14A | View |
Latest News on INBX